Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Electronic Health Record Use in Public Health Infectious Disease Surveillance, USA, 2018-2019.

Willis SJ, Cocoros NM, Randall LM, Ochoa AM, Haney G, Hsu KK, DeMaria A Jr, Klompas M.

Curr Infect Dis Rep. 2019 Aug 26;21(10):32. doi: 10.1007/s11908-019-0694-5. Review.

PMID:
31451945
2.

The Partnerships for Care Project in Massachusetts: Developing Partnerships and Data Systems to Increase Linkage and Engagement in Care for Individuals Living With HIV.

Lewis S, Morrison M, Randall LM, Roosevelt K.

J Acquir Immune Defic Syndr. 2019 Sep 1;82 Suppl 1:S47-S52. doi: 10.1097/QAI.0000000000002020.

PMID:
31425395
3.

Using HIV Surveillance and Clinic Data to Optimize Data to Care Efforts in Community Health Centers in Massachusetts: The Massachusetts Partnerships for Care Project.

Kunzweiler C, Kishore N, John B, Roosevelt K, Lewis S, Klevens RM, Morrison M, Randall LM, DeMaria A Jr.

J Acquir Immune Defic Syndr. 2019 Sep 1;82 Suppl 1:S33-S41. doi: 10.1097/QAI.0000000000002019.

PMID:
31425393
4.

A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.

Randall LM, Wenham RM, Low PS, Dowdy SC, Tanyi JL.

Gynecol Oncol. 2019 Oct;155(1):63-68. doi: 10.1016/j.ygyno.2019.07.010. Epub 2019 Jul 27.

PMID:
31362825
5.

Unraveling the effects of peroxiredoxin 2 nitration; role of C-terminal tyrosine 193.

Randall LM, Dalla Rizza J, Parsonage D, Santos J, Mehl RA, Lowther WT, Poole LB, Denicola A.

Free Radic Biol Med. 2019 Sep;141:492-501. doi: 10.1016/j.freeradbiomed.2019.07.016. Epub 2019 Jul 16.

PMID:
31323313
6.

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.

Tewari KS, Burger RA, Enserro D, Norquist BM, Swisher EM, Brady MF, Bookman MA, Fleming GF, Huang H, Homesley HD, Fowler JM, Greer BE, Boente M, Liang SX, Ye C, Bais C, Randall LM, Chan JK, Ferriss JS, Coleman RL, Aghajanian C, Herzog TJ, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ.

J Clin Oncol. 2019 Sep 10;37(26):2317-2328. doi: 10.1200/JCO.19.01009. Epub 2019 Jun 19.

PMID:
31216226
7.

Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women.

Teo A, Randall LM, Madanitsa M, Mwapasa V, Phiri LK, Khairallah C, Buffet C, Karahalios A, Narum DL, Kuile FOT, Rogerson SJ.

Sci Rep. 2019 May 27;9(1):7878. doi: 10.1038/s41598-019-44340-x.

8.

The Evolving Landscape of Chemotherapy in Newly Diagnosed Advanced Epithelial Ovarian Cancer.

Monk BJ, Randall LM, Grisham RN.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:e141-e151. doi: 10.1200/EDBK_239007. Epub 2019 May 17.

PMID:
31099631
9.

Cost-effectiveness and budgetary impact of HCV testing, treatment and linkage to care in U.S. prisons.

Assoumou SA, Tasillo A, Vellozzi C, Yazdi GE, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP.

Clin Infect Dis. 2019 May 16. pii: ciz383. doi: 10.1093/cid/ciz383. [Epub ahead of print]

PMID:
31095676
10.

Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing Practice.

Randall LM, Birrer MJ, Herzog TJ.

Oncologist. 2019 May;24(5):576-579. doi: 10.1634/theoncologist.2019-0020. Epub 2019 Mar 20. No abstract available.

PMID:
30894410
11.

Rapid progression of disease in two cases of undifferentiated endometrial carcinoma.

Pfaendler KS, Randall LM.

Gynecol Oncol Rep. 2019 Jan 18;27:65-68. doi: 10.1016/j.gore.2019.01.004. eCollection 2019 Feb.

12.

Differential parameters between cytosolic 2-Cys peroxiredoxins, PRDX1 and PRDX2.

Dalla Rizza J, Randall LM, Santos J, Ferrer-Sueta G, Denicola A.

Protein Sci. 2019 Jan;28(1):191-201. doi: 10.1002/pro.3520. Epub 2018 Nov 12.

PMID:
30284335
13.

It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer.

Zivanovic O, Chi DS, Filippova O, Randall LM, Bristow RE, O'Cearbhaill RE.

Gynecol Oncol. 2018 Dec;151(3):555-561. doi: 10.1016/j.ygyno.2018.09.007. Epub 2018 Sep 22. Review.

PMID:
30249527
14.

Differential Kinetics of Two-Cysteine Peroxiredoxin Disulfide Formation Reveal a Novel Model for Peroxide Sensing.

Portillo-Ledesma S, Randall LM, Parsonage D, Dalla Rizza J, Karplus PA, Poole LB, Denicola A, Ferrer-Sueta G.

Biochemistry. 2018 Jun 19;57(24):3416-3424. doi: 10.1021/acs.biochem.8b00188. Epub 2018 Mar 30.

15.

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.

Randall LM, Pothuri B, Swisher EM, Diaz JP, Buchanan A, Witkop CT, Bethan Powell C, Smith EB, Robson ME, Boyd J, Coleman RL, Lu K.

Gynecol Oncol. 2017 Aug;146(2):217-224. doi: 10.1016/j.ygyno.2017.06.002. Epub 2017 Jun 7.

16.

Role and clinical application of next-generation sequencing (NGS) for ovarian cancer.

Lim MC, Randall LM.

J Gynecol Oncol. 2017 Jul;28(4):e51. doi: 10.3802/jgo.2017.28.e51. No abstract available.

17.

Sustained Reduction in HIV Diagnoses in Massachusetts, 2000-2014.

Cranston K, John B, Fukuda HD, Randall LM, Mermin J, Mayer KH, DeMaria A Jr.

Am J Public Health. 2017 May;107(5):794-799. doi: 10.2105/AJPH.2017.303697.

18.

STAT1 Signaling in Astrocytes Is Essential for Control of Infection in the Central Nervous System.

Hidano S, Randall LM, Dawson L, Dietrich HK, Konradt C, Klover PJ, John B, Harris TH, Fang Q, Turek B, Kobayashi T, Hennighausen L, Beiting DP, Koshy AA, Hunter CA.

MBio. 2016 Nov 8;7(6). pii: e01881-16. doi: 10.1128/mBio.01881-16.

19.

The genetic prediction of risk for gynecologic cancers.

Randall LM, Pothuri B.

Gynecol Oncol. 2016 Apr;141(1):10-6. doi: 10.1016/j.ygyno.2016.03.007. Review.

PMID:
27016223
20.

Purification of a recombinant glutathione transferase from the causative agent of hydatidosis, Echinococcus granulosus.

Fleitas AL, Randall LM, Möller MN, Denicola A.

Biochem Mol Biol Educ. 2016 Jan-Feb;44(1):28-37. doi: 10.1002/bmb.20918. Epub 2015 Oct 7.

21.

Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Eskander RN, Ali S, Dellinger T, Lankes HA, Randall LM, Ramirez NC, Monk BJ, Walker JL, Eisenhauer E, Hoang BH.

Int J Gynecol Cancer. 2016 Jan;26(1):125-32. doi: 10.1097/IGC.0000000000000563.

22.

Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmission.

Teo A, Hasang W, Randall LM, Unger HW, Siba PM, Mueller I, Brown GV, Rogerson SJ.

Malar J. 2015 May 26;14:215. doi: 10.1186/s12936-015-0736-x.

23.

Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.

Hodeib M, Chang J, Liu F, Ziogas A, Dilley S, Randall LM, Anton-Culver H, Bristow RE.

Gynecol Oncol. 2015 Jul;138(1):121-7. doi: 10.1016/j.ygyno.2015.04.011. Epub 2015 Apr 22.

24.

The American Society of Clinical Oncology 50th Annual Meeting 2014: an overview and summary of selected abstracts.

Randall LM, Gibson SJ, Monk BJ.

Gynecol Oncol. 2014 Aug;134(2):222-7. doi: 10.1016/j.ygyno.2014.07.086. No abstract available.

PMID:
25090931
25.

Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in patients with recurrent cervical cancer?

Krill LS, Adelson JW, Randall LM, Bristow RE.

Gynecol Oncol. 2014 Sep;134(3):447-9. doi: 10.1016/j.ygyno.2014.06.017. Epub 2014 Jun 27. No abstract available.

PMID:
24976631
26.

Decreasing malaria prevalence and its potential consequences for immunity in pregnant women.

Teo A, Hasang W, Randall LM, Feng G, Bell L, Unger H, Langer C, Beeson JG, Siba PM, Mueller I, Molyneux ME, Brown GV, Rogerson SJ.

J Infect Dis. 2014 Nov 1;210(9):1444-55. doi: 10.1093/infdis/jiu264. Epub 2014 May 5.

PMID:
24799599
27.

Nitration transforms a sensitive peroxiredoxin 2 into a more active and robust peroxidase.

Randall LM, Manta B, Hugo M, Gil M, Batthyàny C, Trujillo M, Poole LB, Denicola A.

J Biol Chem. 2014 May 30;289(22):15536-43. doi: 10.1074/jbc.M113.539213. Epub 2014 Apr 9.

28.

The aryl hydrocarbon receptor promotes IL-10 production by NK cells.

Wagage S, John B, Krock BL, Hall AO, Randall LM, Karp CL, Simon MC, Hunter CA.

J Immunol. 2014 Feb 15;192(4):1661-70. doi: 10.4049/jimmunol.1300497. Epub 2014 Jan 8.

29.

High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.

Bristow RE, Chang J, Ziogas A, Randall LM, Anton-Culver H.

Gynecol Oncol. 2014 Feb;132(2):403-10. doi: 10.1016/j.ygyno.2013.12.017. Epub 2013 Dec 20.

30.

Low antibody levels to pregnancy-specific malaria antigens and heightened cytokine responses associated with severe malaria in pregnancy.

Chandrasiri UP, Randall LM, Saad AA, Bashir AM, Rogerson SJ, Adam I.

J Infect Dis. 2014 May 1;209(9):1408-17. doi: 10.1093/infdis/jit646. Epub 2013 Nov 25.

PMID:
24277742
31.

Racial disparities and patterns of ovarian cancer surgical care in California.

Liu FW, Randall LM, Tewari KS, Bristow RE.

Gynecol Oncol. 2014 Jan;132(1):221-6. doi: 10.1016/j.ygyno.2013.08.035. Epub 2013 Sep 7.

32.

Peroxiredoxins as preferential targets in H2O2-induced signaling.

Randall LM, Ferrer-Sueta G, Denicola A.

Methods Enzymol. 2013;527:41-63. doi: 10.1016/B978-0-12-405882-8.00003-9.

PMID:
23830625
33.

Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.

Eskander RN, Ji T, Huynh B, Wardeh R, Randall LM, Hoang B.

Int J Gynecol Cancer. 2013 Jul;23(6):997-1005. doi: 10.1097/IGC.0b013e318296a265.

34.

Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line.

Eskander RN, Randall LM, Sakai T, Guo Y, Hoang B, Zi X.

J Obstet Gynaecol Res. 2012 Aug;38(8):1086-94. doi: 10.1111/j.1447-0756.2011.01841.x. Epub 2012 Apr 30.

35.

Uterine leiomyomatosis with intracaval and intracardiac extension.

Moniaga NC, Randall LM.

Gynecol Oncol Case Rep. 2012 Sep 5;2(4):130-2. doi: 10.1016/j.gynor.2012.08.003. eCollection 2012.

36.

Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial.

Randall LM, Sill MW, Burger RA, Monk BJ, Buening B, Sorosky JI.

Gynecol Oncol. 2012 Mar;124(3):563-8. doi: 10.1016/j.ygyno.2011.11.035. Epub 2011 Dec 1.

37.

Pivotal advance: peritoneal cavity B-1 B cells have phagocytic and microbicidal capacities and present phagocytosed antigen to CD4+ T cells.

Parra D, Rieger AM, Li J, Zhang YA, Randall LM, Hunter CA, Barreda DR, Sunyer JO.

J Leukoc Biol. 2012 Apr;91(4):525-36. doi: 10.1189/jlb.0711372. Epub 2011 Nov 4.

38.

Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection.

Stanley AC, de Labastida Rivera F, Haque A, Sheel M, Zhou Y, Amante FH, Bunn PT, Randall LM, Pfeffer K, Scheu S, Hickey MJ, Saunders BM, Ware C, Hill GR, Tamada K, Kaye PM, Engwerda CR.

PLoS Pathog. 2011 Oct;7(10):e1002279. doi: 10.1371/journal.ppat.1002279. Epub 2011 Oct 6.

39.

Analysis of behavior and trafficking of dendritic cells within the brain during toxoplasmic encephalitis.

John B, Ricart B, Tait Wojno ED, Harris TH, Randall LM, Christian DA, Gregg B, De Almeida DM, Weninger W, Hammer DA, Hunter CA.

PLoS Pathog. 2011 Sep;7(9):e1002246. doi: 10.1371/journal.ppat.1002246. Epub 2011 Sep 15.

40.

Differentiating squamous cell carcinoma of the cervix and epithelioid trophoblastic tumor.

Jordan S, Randall LM, Karamurzin Y, Ward P, Lin F, Brewster W, Monk BJ.

Int J Gynecol Cancer. 2011 Jul;21(5):918-22. doi: 10.1097/IGC.0b013e31821a278d.

41.

Fertility preserving options in patients with gynecologic malignancies.

Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE.

Am J Obstet Gynecol. 2011 Aug;205(2):103-10. doi: 10.1016/j.ajog.2011.01.025. Epub 2011 Mar 16. Review.

42.

Bevacizumab in the treatment of ovarian cancer.

Eskander RN, Randall LM.

Biologics. 2011;5:1-5. doi: 10.2147/BTT.S13071. Epub 2011 Jan 11.

43.

Parasite dissemination and the pathogenesis of toxoplasmosis.

Randall LM, Hunter CA.

Eur J Microbiol Immunol (Bp). 2011 Mar;1(1):3-9. doi: 10.1556/EuJMI.1.2011.1.3. Review. No abstract available.

44.

A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

Malar J. 2010 Oct 29;9:302. doi: 10.1186/1475-2875-9-302.

45.

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer.

Han ES, Burger RA, Darcy KM, Sill MW, Randall LM, Chase D, Parmakhtiar B, Monk BJ, Greer BE, Connelly P, Degeest K, Fruehauf JP.

Gynecol Oncol. 2010 Dec;119(3):484-90. doi: 10.1016/j.ygyno.2010.08.016. Epub 2010 Sep 25.

46.

Malignant mixed ovarian germ cell tumor with embryonal component.

Moniaga NC, Randall LM.

J Pediatr Adolesc Gynecol. 2011 Feb;24(1):e1-3. doi: 10.1016/j.jpag.2010.05.001. Epub 2010 Sep 24.

47.

Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group Study.

Randall LM, Monk BJ, Moon J, Parker R, Al-Ghazi M, Wilczynski S, Fruehauf JP, Markman M, Burger RA.

Gynecol Oncol. 2010 Dec;119(3):417-21. doi: 10.1016/j.ygyno.2010.08.010. Epub 2010 Sep 16.

48.

Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria.

Amante FH, Haque A, Stanley AC, Rivera Fde L, Randall LM, Wilson YA, Yeo G, Pieper C, Crabb BS, de Koning-Ward TF, Lundie RJ, Good MF, Pinzon-Charry A, Pearson MS, Duke MG, McManus DP, Loukas A, Hill GR, Engwerda CR.

J Immunol. 2010 Sep 15;185(6):3632-42. doi: 10.4049/jimmunol.1000944. Epub 2010 Aug 18.

49.

Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

J Infect Dis. 2010 Jul 1;202(1):117-24. doi: 10.1086/653125.

50.

TNF family members and malaria: old observations, new insights and future directions.

Randall LM, Engwerda CR.

Exp Parasitol. 2010 Nov;126(3):326-31. doi: 10.1016/j.exppara.2010.04.016. Epub 2010 Apr 28. Review.

PMID:
20433831

Supplemental Content

Loading ...
Support Center